Atossa Genetics Inc
Change company Symbol lookup
Select an option...
ATOS Atossa Genetics Inc
CRXPF Crop Infrastructure Corp
MEI Methode Electronics Inc
JPM JPMorgan Chase & Co
C Citigroup Inc
AMZN Amazon.com Inc
LIN Linde PLC
UTX United Technologies Corp
ITUB Itau Unibanco Holding SA
AEE Ameren Corp
Go

Health Care : Health Care Equipment & Supplies | Small Cap ValueCompany profile

Atossa Genetics Inc. is a clinical-stage pharmaceutical company focused on the development of therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The Company's leading program uses its intraductal microcatheters, which deliver pharmaceuticals through the breast ducts. It has initiated a Phase II clinical study using its microcatheters to deliver fulvestrant as a treatment of ductal carcinoma in-situ (DCIS) and breast cancer. Its second pharmaceutical program under development is Afimoxifene Topical Gel (AfTG) for the treatment and prevention of hyperplasia of the breast. It is also engaged in the process of evaluating other therapeutic candidates to treat other breast conditions, including breast cancer. Its medical devices include the ForeCYTE Breast Aspirator and the FullCYTE Breast Aspirator. These devices are intended for the collection of nipple aspirate fluid (NAF) for cytological testing at a laboratory.

Closing Price
$2.08
Day's Change
0.02 (0.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.08
Day's Low
2.03
Volume
(Light)
Volume:
90,770

10-day average volume:
136,504
90,770
  • Prev Close
    2.06
  • Today's Open
    2.04
  • Day's Range
    2.03-2.08
  • Avg Vol (10-day)
    136.5K
  • Last (time)
    4:00p ET 09/20/19
  • Last (size)
    1
  • 52-Wk Range
    0.80 - 7.39
    LowHigh
  • (12/26/18 - 03/14/19)
    160.00%
  • 188.3%
  • Market Cap
    19.0M
  • Shares Outstanding
    9.1M
  • -2.42
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 3.2
  • 2.80
  • (% of float 08/30/19)
    2.94

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.